Overview

2-week dc of MTX and Influenza Vaccination in RA

Status:
Unknown status
Trial end date:
2017-08-01
Target enrollment:
Participant gender:
Summary
To investigate whether a transient discontinuation of methotrexate MTX for 2 weeks improves the vaccination response to a seasonal influenza.
Phase:
N/A
Details
Lead Sponsor:
Seoul National University Hospital
Treatments:
Methotrexate
Vaccines